GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Capex-to-Operating-Income

HLB Science (XKRX:343090) Capex-to-Operating-Income : 0.00 (As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

HLB Science's Capital Expenditure for the three months ended in . 20 was ₩0.00 Mil. Its Operating Income for the three months ended in . 20 was ₩0.00 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


HLB Science Capex-to-Operating-Income Historical Data

The historical data trend for HLB Science's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Capex-to-Operating-Income Chart

HLB Science Annual Data
Trend Dec22 Dec23
Capex-to-Operating-Income
- -

HLB Science Quarterly Data
Capex-to-Operating-Income

Competitive Comparison of HLB Science's Capex-to-Operating-Income

For the Biotechnology subindustry, HLB Science's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HLB Science's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Science's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where HLB Science's Capex-to-Operating-Income falls into.



HLB Science Capex-to-Operating-Income Calculation

HLB Science's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-17.369) / -2680.564
=N/A

HLB Science's Capex-to-Operating-Income for the quarter that ended in . 20 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- () /
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HLB Science  (XKRX:343090) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


HLB Science Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of HLB Science's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science (XKRX:343090) Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines